A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
Phase of Trial: Phase II
Latest Information Update: 09 Jan 2017
At a glance
- Drugs Corticotropin (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Adverse reactions
- Sponsors Mallinckrodt plc; Questcor Pharmaceuticals
- 21 Nov 2016 Status changed from active, no longer recruiting to completed, according to a Mallinckrodt LLC media release.
- 04 Apr 2014 Planned End Date changed from 1 Oct 2014 to 1 Dec 2014 as reported by ClinicalTrials.gov record.
- 18 Feb 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.